India gets Covid-19 vaccine. But is the problem solved?

  • 3 years ago
The Drugs Controller General of India’s restricted emergency approval to Bharat Biotech’s Covaxin has raised questions over the transparency of the process of granting approvals. India's hmegrown vaccine is under controversy now and the question is - How can a Covid-19 vaccine be cleared for emergency use by millions of vulnerable people in a "clinical trial" mode? For more, watch the full video.

Recommended